Specific thresholds of circulating antibody titers predict against infection and reduced disease severity in SARS-CoV-2 close contacts

Higher circulating SARS-CoV-2 IgG titers correlate with SARS-CoV-2 ex vivo viral neutralization, but how well this translates to clinical protection in the real-world setting is unclear. In a prospective cohort study, we enrolled 44 SARS-CoV-2 negative, confirmed SARS-CoV-2 close contacts. Receptor-binding domain (RBD) and full-spike IgG and SARS-CoV-2 memory B-cell frequencies were measured at exposure, and participants were serially tested for incident infection over 14 days. Those who developed SARS-CoV-2 infection had significantly lower RBD titers, but not memory B-cell frequencies. An RBD IgG titer >6321 BAU/ml was associated with a reduced SARS-CoV-2 acquisition risk (HR 0.32, 95% CI 0.13-0.81), while an RBD IgG titer >456 BAU/ml was associated with a reduced moderate or severe COVID-19 risk (HR 0.15, 95% CI 0.03-0.81), identifying this threshold as a correlate of protection.

Authors

Institutions

Publication Details

Journal
The Journal of Immunology
Published
2025-05-22
DOI
https://doi.org/10.1093/jimmun/vkaf101
Citations
1
Primary Topic
SARS-CoV-2 and COVID-19 Research
Type
article
Field-Weighted Citation Impact
1.40

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Specific thresholds of circulating antibody titers predict against infection and reduced disease severity in SARS-CoV-2 close contacts

Peter Doran, Gurvin Saini, Jane A. O’Halloran, Alan Landay et al.
1 citations
The Journal of Immunology
SARS-CoV-2 and COVID-19 Research
1.40
article

Specific thresholds of circulating antibody titers predict against infection and reduced disease severity in SARS-CoV-2 close contacts

Peter Doran, Gurvin Saini, Jane A. O’Halloran, Alan Landay, Patrick Mallon, Mary M. Horgan, Eoin R. Feeney, Virginie Gautier, Siobhan O’Regan, Orlaith Casey, Joanne Byrne, Colette Marie Gaillard, Corinna Sadlier, Dana Alalwan, A. Léon, Tessa O’Gorman, Lili Gu, Aoife G. Cotter, Eoghan de Barra, Grace Kenny
article en
1 citations

Abstract

Higher circulating SARS-CoV-2 IgG titers correlate with SARS-CoV-2 ex vivo viral neutralization, but how well this translates to clinical protection in the real-world setting is unclear. In a prospective cohort study, we enrolled 44 SARS-CoV-2 negative, confirmed SARS-CoV-2 close contacts. Receptor-binding domain (RBD) and full-spike IgG and SARS-CoV-2 memory B-cell frequencies were measured at exposure, and participants were serially tested for incident infection over 14 days. Those who developed SARS-CoV-2 infection had significantly lower RBD titers, but not memory B-cell frequencies. An RBD IgG titer >6321 BAU/ml was associated with a reduced SARS-CoV-2 acquisition risk (HR 0.32, 95% CI 0.13-0.81), while an RBD IgG titer >456 BAU/ml was associated with a reduced moderate or severe COVID-19 risk (HR 0.15, 95% CI 0.03-0.81), identifying this threshold as a correlate of protection.

The Journal of ImmunologyVol. 214(9)
University College Dublin (IE), Royal College of Surgeons in Ireland (IE), Beaumont Hospital (IE), Cork University Hospital (IE), Mater Misericordiae University Hospital (IE), St. Vincent's University Hospital (IE), The University of Texas Medical Branch at Galveston (US)
Science Foundation Ireland
Good health and well-being
Openalex Percentile: Top 20%
SARS-CoV-2 and COVID-19 Research
1.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.